Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Tanta University

Status and phase: Enrolling; Phase 3

Conditions: Helicobacter Pylori Infection

Treatments: Drug: Proton pump inhibitor; Drug: Clarithromycin; Drug: Metronidazole; Drug: Nitazoxanide

Study type: Interventional

Funder types: Other

Identifiers

NCT04415983

helicobacter children

Details and patient eligibility

About

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Full description

Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children

Enrollment: 100 estimated patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Positive helicobacter infection.

Exclusion criteria

• Previous treatment for H. Pylori.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

100 participants in 2 patient groups

Nitazoxanide group

Experimental group

Description:

Clarithromycin, Nitazoxanide and Proton pump inhibitor

Treatment:

Drug: Nitazoxanide

Drug: Clarithromycin

Drug: Proton pump inhibitor

Traditional group

Active Comparator group

Description:

Clarithromycin, Metronidazole and Proton pump inhibitor

Treatment:

Drug: Metronidazole

Drug: Clarithromycin

Drug: Proton pump inhibitor